A US-based national surveillance study for the susceptibility and epidemiology of <i>Clostridioides difficile</i> isolates with special reference to ridinilazole: 2020–2021David R. Snydman, Esther Duperchy, Cheleste M. Thorpe et al.|Antimicrobial Agents and Chemotherapy|2023Cited by 15